To further prove and examine the effects of artesunate on GlyRs in conditions that mimic an AD environment, we treated cultured hippocampal neurons that expressed the human APPswe protein with increasing concentrations of artesunate (from 0.1 μM to 1 μM) for seven days. This evidence concerns the gene GARS1 and Alzheimer disease.